Evidence map›Paper›PMID 35354926›Full record

ReviewMolecular psychiatry2022

Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.

Alexandria N Tartt, Madeline B Mariani, Rene Hen, J John Mann, Maura Boldrini

Open access · greenAbstract readReview
In one paragraph

Review in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed, 9 pooled it
42.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 9 syntheses or guidelines pooled it, 360 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Glutamine metabolism in health and disease.Signal transduction and targeted therapy · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  17. Article
  18. Ketamine and Evolving Neuroplasticity.Clinical drug investigation · 2026
    Review
  19. Review
  20. Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Alexandria N TarttStanford University School of Medicine, Stanford, CA, USA.
Madeline B MarianiDepartments of Psychiatry, Columbia University, New York, NY, USA.
Rene HenDepartments of Psychiatry, Columbia University, New York, NY, USA.
J John MannDepartments of Psychiatry, Columbia University, New York, NY, USA.
Maura BoldriniDepartments of Psychiatry, Columbia University, New York, NY, USA. mb928@cumc.columbia.edu.ORCID http://orcid.org/0000-0003-3574-7641
Columbia University · USColumbia University Irving Medical Center · USNeurosciences Institute · USNew York Psychoanalytic Society and Institute · USStanford University · US

Funding

Effect of Major Depression and antidepressants on human neurogenesisR01MH083862 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BOLDRINI, MAURA, HEN, RENE · 2009 to 2018
$5.4M
New technologies to identify molecular regulators of the human hippocampus neurogenic niche in healthy aging and Alzheimer's DiseaseR01AG076949 · NIA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Maura Boldrini Dupont · 2022 to 2026
$4.4M
Hippocampal circuit plasticity in human normal aging and Alzheimer's DiseaseR56AG063372 · NIA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BOLDRINI, MAURA · 2020 to 2020
$760k
Trophic factors and regulation of hippocampal neuroplasticity in the human brainR21MH094888 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BOLDRINI, MAURA · 2011 to 2012
$454k
How the Novel Coronavirus Attacks the BrainR21AI164769 · NIAID · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BOLDRINI, MAURA · 2021 to 2022
$442k
NIAID NIH HHS R21 AI164769NIA NIH HHS R01 AG076949NIA NIH HHS R56 AG063372NIMH NIH HHS R01 MH083862NIMH NIH HHS R21 MH094888
6 · The paper itself

Abstract

Major depressive disorder (MDD) was previously hypothesized to be a disease of monoamine deficiency in which low levels of monoamines in the synaptic cleft were believed to underlie depressive symptoms. More recently, however, there has been a paradigm shift toward a neuroplasticity hypothesis of depression in which downstream effects of antidepressants, such as increased neurogenesis, contribute to improvements in cognition and mood. This review takes a top-down approach to assess how changes in behavior and hippocampal-dependent circuits may be attributed to abnormalities at the molecular, structural, and synaptic level. We conclude with a discussion of how antidepressant treatments share a common effect in modulating neuroplasticity and consider outstanding questions and future perspectives.

Indexed as

Major Depressive DisorderAdultAntidepressive AgentsDepressionHippocampusHumansNeuronal PlasticityAntidepressive Agents

Identifiers

PMID35354926
PMCPMC9167750
OpenAlexW4221105875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.